Professor Ram Sasisekharan and research scientist Kannan Tharakaraman have found that a strain of H1N1 influenza in India is more virulent than health authorities have indicated, writes Rishi Lyengar of Time. “They found mutations in the Indian strains in a protein called hemagglutinin, which binds with receptors on the human body’s respiratory cells,” Lyengar writes.
Laura Santhanam writes for the PBS NewsHour that MIT researchers have found that a strain of swine flu in India is more dangerous than originally thought. The researchers found that “a mutation in the new H1N1 strain allows this form of swine flu to attack an infected person’s respiratory cells more virulently.”
Prof. Robert Langer speaks with Chris Baraniuk of New Scientist about winning the Queen Elizabeth Prize for Engineering and his career in biotechnology. “It’s going to be the entrepreneurs, the new professors, the young people who are willing to think outside the box and not necessarily go down a conventional path,” says Langer of the future of medicine.
Michelle Roberts reports for BBC News on a new, “smart insulin” being developed by MIT researchers that switches on when blood sugar rises. The engineered insulin could make it easier for those suffering from diabetes to manage the disease, Roberts explains.
Professor Robert Langer has won the Queen Elizabeth Prize for Engineering for his pioneering work with medical technologies, reports David Shukman for BBC News. Shukman notes that “as many as two billion people have in some way been touched by technologies devised and developed by him and his teams.”
Nidhi Subbaraman reports for BetaBoston that Professor Robert Langer has been named the recipient of the Queen Elizabeth Prize for Engineering for his research on tissue engineering and drug delivery. “It’s a real thrill, a real honor,” says Langer. “I feel incredible lucky.”
Prof. Robert Langer has been awarded the Queen Elizabeth Prize for Engineering, writes Financial Times reporter Clive Cookson. Lord Broers, chair of the QE Prize judges, explains that Langer was honored for his “immense contribution to healthcare and to numerous other fields.”
Prof. Robert Langer speaks with Trisha Gura of Science about his work as an engineer and entrepreneur. Says Langer of how he became an entrepreneur, “I could see that by having these little companies, you could make an enormous impact.”
Boston Globe reporter Callum Borchers writes about how MIT researchers have developed a new coating that could reduce the risk posed by ingesting batteries. The battery has “been shown in lab tests to deactivate an ingested battery without compromising its performance in electronic devices,” writes Borchers.
In a piece for The Atlantic, Sarah Laskow writes about how MIT researchers have developed a new drug-delivery capsule that could serve as an alternative to injections. The new drug capsule would make it possible to “deliver drugs that would otherwise break down in the digestive tract.”
Reporting for Scientific American, Cynthia Graber examines how MIT researchers have developed a battery coating that reduces the risk of injury if swallowed. Inside the coating, “microparticles of conductive metal are suspended in an insulating layer,” Graber explains.
BBC News reporter Jonathan Webb writes that researchers from MIT have created child-safe batteries by developing a coating that allows batteries to conduct electricity only when squeezed. The “pressure-sensitive design makes use of a property called quantum tunneling, which is also used in touch pads and screens,” writes Webb.
Alison Bruzek of NPR reports that MIT researchers have developed a shield that can prevent the electrical currents in a battery from damaging the esophagus. The material used to create the shield is already commercially available, NPR reports, making the coating a cheap solution to the issue of children swallowing batteries.
Atlantic reporter Cari Romm reports on how MIT researchers have devised an alternative drug-delivery method: A pill covered with tiny needles. The researchers plan to improve their current design by creating a “fully biodegradable version of the pill.”
WCVB reports that researchers from MIT and Massachusetts General Hospital have developed a pill coated with tiny needles that can deliver drugs directly into the digestive tract. The pill was found to deliver insulin more efficiently than current methods, WCVB reports.